Contact this trialFirst, we need to learn more about you.
Olanzapine for Appetite Loss in Cancer
Recruiting0 awardsPhase 2
Portland, Oregon
This trial tests if olanzapine can help cancer patients with appetite loss, weakness, and fatigue due to cachexia. It targets neurotransmitters to stimulate appetite, restore calories, and improve quality of life.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.